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Peripheral Venous Catheter–Related Adverse
Events in a Tropical Country
Peripheral venous catheterization (PVC) is one of the most
common procedures performed among hospitalized patients.
However, 1%–10% of patients who undergo PVC develop local
or systemic complications including phlebitis, infiltration,
occlusion, tissue extravasation, and rarely, infection.1–6 The
frequency of these complications may vary depending on the
type of catheter, insertion site preparation, type of infusate,
insertion technique, duration of catheterization, dressing type,
and insertion site.1–6 Most studies evaluating PVC-related
adverse events (PVCAEs) have been performed in United States
and Europe.4,5,7–9 Generalization of these findings to tropical
countries may be inappropriate given the high temperature and
humidity, which may impact the duration of catheterization
and the need for dressing changes. Data regarding PVCAEs in
tropical countries are scarce. A prospective cohort study was
conducted to evaluate the incidence, type, and associated factors
of adverse events associated with PVCs.
From January 1, 2017, to March 31, 2017, 5 research nurses
prospectively followed all hospitalized patients at Thammasat
University Hospital, a 650-bed, tertiary hospital in Thailand.
They also inspected and monitored all inserted PVCs daily for
complications. From all hospitalized patients >15 years old
with a PVC, consent for study participation was obtained. Each
patient with a PVC in place for >24 hours was prospectively
followed until PVC removal or complications occurred. Data
collected included patient demographics, hospital location of
PVC insertion(s), skin condition, Charlson comorbidity score,
anatomical site of PVC, inserter, total duration of PVC and
PVCAEs. Complications related to PVCs were categorized as
mechanical or clinical PVCAEs. Each PVCAE was first
recorded as a suspected event based on daily collection of the
presence or absence of signs and/or symptoms during
catheterization and up to 48 hours after catheter removal. A
mechanical PVCAE was defined as any catheter dislodgement
that was unplanned, an occlusion of the PVC, or a rupture of
the closed infusion system when infusion lines were
disconnected from the infusion bag or the absence of a
well-sealed injection site. Clinical PVCAEs included localized
edema at the site of insertion, phlebitis, hematoma at the
insertion site, leakage of fluid/blood and suspected sepsis.
Signs and symptoms recorded included redness and/or
warmth, tenderness and/or pain, edema and/or swelling,
induration, palpable venous cord, and presence of pus,
hematoma, and/or fever (when concomitant with another
symptom or sign). The grading for phlebitis was modeled from
Maddox et al.10
Analyses were performed using SPSS software version 15
(IBM, Armonk, NY), and categorical data were compared using
the 2-tailed χ2 or Fisher’s exact test, as appropriate. The Mann-
Whitney U test was used to compare continuous variables.
Logistic regression was performed to assess predictors for out-
comes (any PVCAEs). Adjustment was made for key variables
including severity of illness, patient characteristics, settings of
insertion, and anatomical of catheter insertions. Adjusted odd
ratio (aOR) and 95% confidence intervals (CIs) were com-
puted; a significant statistical difference was defined as P< .05.
In total, 646 PVCs were placed in 500 hospitalized patients
during the study period. The median age was 64 years
(range, 49–76 years). The frequency and percentage of
Charlson scores were as follows: 0–1 (254 of 500, 51.8%), 2–3
(180 of 500, 36.0%), and >3 (66 of 500, 13.2%). Overall, the
median number of PVCs per patient was 1 (range, 1–7). Most
PVCs were placed in medical units (58 of 646; 39.9%) or
surgical units (155 of 646, 24%), and PVCs were most com-
monly inserted into the hand (271 of 646, 42%) or forearm
(187 of 646, 29%). The median dwelling time was 3 days
(range, 1–24 days); 20.8% of PVCAE patients (104 of 500) had
a PVC >3 days. The overall PVCAE rate was 61.1 PVCAEs per
1,000 PVC days. The most common complications were
occlusion (24.4 of 1,000 PVC days), phlebitis (19.1 of 1,000
PVC days), and PVC leakage (16 of 1, 000 PVC days) (Table 1).
Mechanical PVCAEs were more common than clinical
PVCAEs (P= .01). Most PVCAEs occurred during the first
3 days after PVC insertion. There was no significant difference
between time to mechanical PVCAE versus clinical PVCAE
nor the rates of complications from different insertion sites. By
multivariate analysis, being female (aOR, 1.6; 95% CI, 1.08–
3.36; P= .02), unstable PVC (aOR, 1.9; 95% CI, 1.24–6.45;
P= .04), and presence of cutaneous lesions (aOR, 2.2; 95% CI,
1.45–5.67; P= .01) were independent risk factors for any
PVCAEs, while a covered transparent dressing (aOR, 0.78;
95% CI, 0.55–0.92; P= .02) was protective.
Our findings highlight several key issues. First, despite the
lower incidence of infection-related PVCAEs, the burden of
PVCAEs in this tropical country was high compared to pre-
viously reported studies in nontropical countries.2,5–9 Second,
the proportion of patients who had a PVC for>3 days was low,
likely due to the high temperature and humidity. Although a
recent recommendation suggested no benefit of routine PVC
replacement (ie, between 72 and 96 hours),1 our data suggest
that high temperature and humidity may have impacted on
shorter duration of PVC replacement (Table 1).7 Third, our
data emphasize the need for meticulous care of PVC during
insertion and maintenance. To minimize the risk of occlusion,
the PVC needs to be stabilized; a transparent dressing should
be used for PVC maintenance.
This study has several limitations. First, given the nature of
this pilot study, we did not collect clinical conditions (eg, sepsis),
nor did we assess all known risk factors associated with PVCAEs
including type of infusate, catheter material, and type of cannula
dressing.2,4–10 Second, our PVCAE definition was derived
mainly from clinical parameters, and >50% of the study popu-
lationwere elderly. Third, the small sample size in our studymay
have limited our capacity to identify other potential risk factors
associated with PVCAEs. Despite these limitations, our study
results suggest that the PVCAE burden is underestimated in this
tropical country. Proper training for PVC insertion, main-
tenance, and monitoring after PVC insertion are crucial com-
ponents of improving care to prevent PVCAEs in tropical
countries with high humidity and temperature.
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table 1. Patient Characteristics and Peripheral Venous Catheter–













No. of PVCs, median (range) 1 (1–7)







Hospital unit at insertion
Medicine 200 (40)
Surgery 124 (24.8)
Intensive care 95 (19)
Others 81 (16.2)
Documentation of dressing 339 (67.8)
Type of dressing
Nonocclusive dressing 36 (7.2)
Unclean dressing 59 (11.8)
Covered transparent dressing 405 (81)
Duration of PVC, median d (range) 3 (1–24)
Total PVC days 2,594
Incidence of PVCAEs per 1,000 PVC days
Mechanical 45.96
Clinical 27.52







NOTE. PVC, peripheral venous catheter.
